Business performance and slower market growth require adjustment of guidance for 2025 – Biotech Investments

by Biotech Newsroom


Gerresheimer AG: Business performance and slower market growth require adjustment of guidance for 2025

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group.

The issuer is solely responsible for the content of this announcement.

Gerresheimer AG: Business performance and slower market growth require adjustment of guidance for 2025

Duesseldorf, October 8, 2025. Gerresheimer AG (ISIN: DE000A0LD6E6, “Gerresheimer”) is adjusting its guidance for the…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC